ImmunityBio (IBRX) Change in Inventory (2024 - 2026)
ImmunityBio (IBRX) posted quarterly Change in Inventory of $5.0 million for Q1 2026, up 2798.26% year-over-year from $172000.0 in Q1 2025, and down 36.85% quarter-over-quarter from $7.9 million in Q4 2025.
Powered by 
Analysis
ImmunityBio (IBRX) Change in Inventory (2024 - 2026) Analysis & Trends
ImmunityBio (IBRX) has reported Change in Inventory for 3 consecutive years, with $5.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory rose 2798.26% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $11.1 million (up 31.9% YoY), while the FY2025 annual figure was $6.3 million, down 23.54% from the prior year.
- Change in Inventory slipped to $5.0 million in Q1 2026 per IBRX's latest filing, from $7.9 million in the prior quarter.
- Across five years, Change in Inventory topped out at $7.9 million in Q4 2025 and bottomed at -$1.8 million in Q2 2025.
- Historically, Change in Inventory has averaged $2.4 million across 3 years, with a median of $991500.0 in 2024.
- Annual changes were most pronounced in 2025 — Change in Inventory tumbled 199.61% — and 2026, when it jumped 2798.26%.
- ImmunityBio's Change in Inventory stood at $6.3 million in 2024, then rose by 25.02% to $7.9 million in 2025, then sank by 36.85% to $5.0 million in 2026.
- Business Quant data shows IBRX's Change in Inventory at $5.0 million in Q1 2026, $7.9 million in Q4 2025, and $63000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 10 | ImmunityBio | 8.51 Bn | 8.15 Bn | 50.94 Mn | -1.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.01 Mn |
| Mar 31, 2026 | 4.99 Mn |
| Dec 31, 2025 | 7.89 Mn |
| Sep 30, 2025 | 63,000.00 |
| Jun 30, 2025 | -1.80 Mn |
| Mar 31, 2025 | 172,000.00 |
| Dec 31, 2024 | 6.31 Mn |
| Sep 30, 2024 | 147,000.00 |
| Jun 30, 2024 | 1.81 Mn |